![](/documents/10803/1033543/New+study+of+therapy+options+in+metastatic+melanoma_thumbnail.jpg/3afabf48-e435-7107-6605-b3b6b42825f5?t=1600453272777)
New study of therapy options in metastatic melanoma
RI-MUHC researchers lead “real-world” analysis of treatment patterns with checkpoint inhibitors
![](/documents/10803/1000714/Lashanda+Skerritt+awarded+Vanier+Canada+Graduate+Scholarship+thumbnail.jpg/c13440e0-b560-fe74-277a-f5c861ce4a47?t=1598472000944)
Lashanda Skerritt awarded Vanier Canada Graduate Scholarship
“I am constantly reminded that community involvement and advocacy are important drivers of scientific and medical knowledge,” says the RI-MUHC...
![](/documents/10803/1014936/Inappropriate+prescriptions+sending+hospitalized+seniors+back+to+the+ER+thumbnail.jpg/988c4386-5fad-4634-b117-5fd8d057e90a?t=1597260594276)
Inappropriate prescriptions sending hospitalized seniors back to the ER
Improving hospital prescribing practices may reduce risk of rehospitalization and death
![](/documents/10803/987147/Early+treatment+trial+of+hydroxychloroquine+shows+no+symptomatic+benefit+for+COVID-19+patients+tumbnail.png/50ee39fa-6ccf-588c-29ad-1e392d468874?t=1594996005809)
Early treatment trial of hydroxychloroquine shows no symptomatic benefit for COVID-19 patients
Adult outpatients with mild symptoms of COVID-19 don’t benefit from taking hydroxychloroquine
![](/documents/10803/996653/A+good+showing+for+the+IDIGH+Program+in+2020-2021+FRQS+awards+thumbnail.jpg/6ebfb059-095d-e4f8-d361-9e8fb7793b2b?t=1594842513252)
A good showing for the IDIGH Program in 2020-2021 FRQS awards
Congratulations to researchers and trainees!
![](/documents/10803/993134/Mikashmi-thumbnail.jpg)
Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli
A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics
![](/documents/10803/941785/Three+COVID-19+projects+at+the+RI-MUHC+to+receive+CIHR+funding+thumbnail.jpg/35299054-b9e1-cf5e-72b3-82cb85e06725?t=1593193199353)
Three COVID-19 projects at the RI-MUHC to receive CIHR funding
A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease
![](/documents/10803/946541/COVID-19+pandemic+Looking+back+to+better+tackle+future+challenges+thumbnail.jpg/41d85882-0c2c-440e-500f-3c833a2f243b?t=1593091160157)
COVID-19 pandemic: Looking back to better tackle future challenges
In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies
![](/documents/10803/941785/Innovation+Moves+Online+for+the+2020+McGill+Clinical+Innovation+Competition+thumbnail.jpg/d0a397e6-77b0-d590-06fb-4f0773be897d?t=1591899516549)
Innovation Moves Online for the 2020 McGill Clinical Innovation Competition
RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize
![](/documents/10803/934345/COVID-19+impact+on+cancer+patients+MUHC+researchers+take+part+in+a+multinational+study_thumbnail.jpg/9b38efed-f0bf-a497-1e93-9bbccfd17ce3?t=1591806802300)
COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study
Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality